Depression and Medication Adherence in the Treatment of Chronic Diseases in the United States: A Meta-Analysis
- First Online:
- 1.4k Downloads
To conduct a meta-analysis of the association between depression and medication adherence among patients with chronic diseases. Poor medication adherence may result in worse outcomes and higher costs than if patients fully adhere to their medication regimens.
We searched the PubMed and PsycINFO databases, conducted forward searches for articles that cited major review articles, and examined the reference lists of relevant articles.
Study Eligibility Criteria, Participants, and Interventions
We included studies on adults in the United States that reported bivariate relationships between depression and medication adherence. We excluded studies on special populations (e.g., substance abusers) that were not representative of the general adult population with chronic diseases, studies on certain diseases (e.g., HIV) that required special adherence protocols, and studies on interventions for medication adherence.
Study Appraisal and Synthesis Methods
Data abstracted included the study population, the protocol, measures of depression and adherence, and the quantitative association between depression and medication adherence. Synthesis of the data followed established statistical procedures for meta-analysis.
The estimated odds of a depressed patient being non-adherent are 1.76 times the odds of a non-depressed patient, across 31 studies and 18,245 participants. The association was similar across disease types but was not as strong among studies that used pharmacy records compared to self-report and electronic cap measures.
The meta-analysis results are correlations limiting causal inferences, and there is some heterogeneity among the studies in participant characteristics, diseases studied, and methods used.
This analysis provides evidence that depression is associated with poor adherence to medication across a range of chronic diseases, and we find a new potential effect of adherence measurement type on this relationship. Although this study cannot assess causality, it supports the importance that must be placed on depression in studies that assess adherence and attempt to improve it.
KEY WORDSdepression adherence chronic disease meta-analysis
- 2.World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva, Switzerland: World Health Organization; 2003.Google Scholar
- 3.National Council on Patient Information and Education. Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Bethesda, MD; 2007.Google Scholar
- 7.Hiligsmann M, Rabenda V, Bruyere O, Reginster JY. The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients. Health Policy. 2010;96:170–7.Google Scholar
- 8.Hiligsmann M, Rabenda V, Gathon HJ, Ethgen O, Reginster JY. Potential clinical and economic impact of nonadherence with osteoporosis medications. Calcif Tissue Int. 2010;86:202–10.Google Scholar
- 9.Davis KL, Edin HM, Allen JK. Prevalence and cost of medication nonadherence in Parkinson's disease: Evidence from administrative claims data. Mov Disord. 2010;25:474–80.Google Scholar
- 13.Breitscheidel L, Stamenitis S, Dippel FW, Schoffski O. Economic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: A review paper. J Med Econ. 2010;13:8-15.Google Scholar
- 18.Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008 CD000011.Google Scholar
- 20.DiMatteo MR. The role of effective communication with children and their families in fostering adherence to pediatric regimens. Patient Educ Counsel Special Issue: Educating and Counseling Children about Physical Health. 2004;55:339–344.Google Scholar
- 27.Rosenthal R. Meta-analytic procedures for social research. Applied social research methods series. London: Sage; 1984.Google Scholar
- 37.Hedges LV, Olkin I. Statistical methods for meta-analysis. San Diego, CA: Academic Press; 1985:xxii–369.Google Scholar
- 39.Friedman DS, Okeke CO, Jampel HD, et al. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology. 2009; 116:1097-105.Google Scholar
- 40.Ross SM. Simulation. 4th ed. Amsterdam: Elsevier Academic Press; 2006:xiii–298 s.Google Scholar
- 41.Pearson K. Mathematical contributions to the theory of evolution. Vii, viii. Proceedings of the Royal Society. 1900; LXVI:140-164, 241-244.Google Scholar
- 42.Rosenthal R, Rosnow RL, Rubin DB. Contrasts and effect sizes in behavioral research: A correlational approach. New York, NY US: Cambridge University Press; 2000.Google Scholar
- 44.StataCorp. Stata statistical software. In: Release 10. College Station. TX: StataCorp LP; 2007.Google Scholar
- 57.Gellad WF, Grenard JL, McGlynn EA. A review of barriers to medication adherence. In: A framework for driving policy options. Santa Monica, CA: RAND Corp; 2009.Google Scholar
- 62.Cruess DG, Localio AR, Platt AB, et al. Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics. Int J Behav Med. 2010; 17:33–42.Google Scholar
- 68.Mann DM, Ponieman D, Leventhal H, Halm EA. Predictors of adherence to diabetes medications: The role of disease and medication beliefs. J Behav Med. 2009;32:278–84.Google Scholar
- 75.Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009; 75:1223–9.Google Scholar
- 85.Davis DP, Jandrisevits MD, Iles S, Weber TR, Gallo LC. Demographic, socioeconomic, and psychological factors related to medication non-adherence among emergency department patients. J Emerg Med. Epub 2009 May 21.Google Scholar